Your session is about to expire
← Back to Search
On-screen electronic alert for Stroke
N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
Electronic Alerts for Stroke Prevention in Atrial Fibrillation
Eligible Conditions
- Stroke
- Atrial Fibrillation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
frequency of prescription of anticoagulation in high-risk AF patients in the outpatient setting who are not being prescribed anticoagulation
Secondary outcome measures
frequency of major bleeding (as defined by the ISTH bleeding classification system)
frequency of stroke/TIA, systemic embolism, myocardial infarction and all-cause mortality
Other outcome measures
frequency of all-cause mortality
frequency of myocardial infarction
frequency of stroke, TIA, systemic embolism
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Electronic AlertExperimental Treatment1 Intervention
Each provider in the alert group will receive an on-screen notification regarding the patient's increased risk of stroke in AF and the lack of an active order for anticoagulation.
Group II: No AlertActive Control1 Intervention
Each provider in the non-alert group will receive no such notification.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
On-screen electronic alert
2018
N/A
~800
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,608 Previous Clinical Trials
11,469,079 Total Patients Enrolled
16 Trials studying Stroke
1,167,700 Patients Enrolled for Stroke
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger